Healthcare >> CEO Interviews >> April 5, 2010
Dr. Yahia Gawad is Founder, CEO and Director of CardioGenics Holdings, Inc. He was a Co-Founder of Syn X, previously Skye Pharmatech, where he held the position of Vice President, Medical Affairs. Prior to that, he was Director of Clinical Research at Spectral Diagnostics, Inc. For the last 18 years, Dr. Gawad has worked extensively on cardiac diagnostic test products, which he took from concept and bench development to commercialization and regulatory approval processes. Dr. Gawad is a physician and scientist with primary training in cardiology, biochemistry and immunology. Profile
TWST: Give us a brief history of CardioGenics and an overview of what you do.
Dr. Gawad: We started CardioGenics (CHNG)in November 1997, and operations commenced in early 1998. We develop products
